Clinical Trials Browser

Phase NA × Constriction, Pathologic × 30 days × Clear all

NCT05149755 2026-03-17

Evolut™ EXPAND TAVR II Pivotal Trial

Phase NA Active not recruiting

Constriction, Pathologic, Lymphoma, Follicular